← SynDRA
HEXAFLUORENIUM
SynDRA canonical compound SYN0023552 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | BCHE |
|---|
| Mechanism of action | acetylcholinesterase inhibitor |
|---|
| Indication | muscle relaxant |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- ACHE INHIBITOR
- Acetylcholinesterase inhibitor
- BCHE INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- DRD3
- SLC6A4
- HTR1A
- HRH3
- SLC6A2
- SLC6A3
- OPRM1
- CHRM2
- CHRM1
- ADRA2A
- ADRA1A
- PDE3A
- TBXA2R
- PTGS1
- PGR
- PDE4A
- ADORA1
- HTR2B
- MAOA
- KDR
- ADORA3
- F2
- ESR1
- DRD1
- AR
- TDP1
Drug classes
- Cholinergic Agents
- Cholinergic Antagonists
- Neurotransmitter Agents
- Nicotinic Antagonists
ATC classes
- M03A · MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Cross-references
Synonyms
- MYLAXEN
- hexafluronium
- hexafluorenium bromide
- hexafluorenium dibromide
- hexafluronium bromide
- Hexafluronium
- Hexafluorenium cation
- Hexafluorenium ion
- Hexamethylenebis(fluoren-9-yldimethylammonium)
- Ammonium, hexamethylenebis(fluoren-9-yldimethyl-
- RefChem:146000
- DTXCID20197284
- Ammonium, Hexamethylenebis(fluoren-9-yldimethyl)-
- HEXAFLURONE BROMIDE
- NCGC00182971-01
- HEXAFLUORENIUM [VANDF]
- SCHEMBL487495
- UNII-55W5L6G81R
- HEXAFLURONIUM [WHO-DD]
- SCHEMBL30299003
- HSDB 3230
- CHEBI:135804
- BDBM50016845
- NS00068673
- hexafluroenium
- hexafluroniumbromide
- HEXAFLURONIUM BROMIDE [MART.]
- Hexafluorenium bromide
- Hexaflurone bromide
- DTXCID9028679
- NSC-19477
- Hexafluorenium bromide [USAN:USP]
- Esafluronio bromuro
- EBC-27419
- DA-74107
- WDEFPRUEZRUYNW-UHFFFAOYSA-L
- 1,6-Bis(9 fluorenyldimethyl-ammonium)hexane bromide
Look up HEXAFLUORENIUM in the interactive SynDRA portal →